FDA-Approved

Compounds with at least one FDA-approved pharmaceutical form. Research notes describe the compound class as studied in published literature. Showing 3 compounds.

← All categories
PT-141 (Bremelanotide) FDA-approved melanocortin receptor agonist for hypoactive sexual desire disorder. View research notes → Semaglutide FDA-approved GLP-1 agonist (Ozempic, Wegovy) for diabetes and weight management. View research notes → Tirzepatide FDA-approved dual GIP/GLP-1 agonist (Mounjaro, Zepbound) for diabetes and obesity. View research notes → Tesamorelin Tesamorelin is a 44-amino acid synthetic analog of growth hormone-releasing hormone (GHRH), the hypothalamic peptide that signals the anterior pituitary to release growth hormone. View research notes →